cached image

Godfrey S. Getz - Publications

Affiliations: 
University of Chicago, Chicago, IL 
Area:
Cell Biology, Molecular Biology
Website:
https://pathology.uchicago.edu/directory/godfrey-s-getz-md-phd

93 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Rodriguez A, Trigatti BL, Mineo C, Knaack D, Wilkins JT, Sahoo D, Asztalos BF, Mora S, Cuchel M, Pownall HJ, Rosales C, Bernatchez P, Ribeiro Martins da Silva A, Getz GS, Barber JL, et al. Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA119313340. PMID 31597448 DOI: 10.1161/ATVBAHA.119.313340  0.32
2019 VanderLaan PA, Reardon CA, Cabana VG, Wang CR, Getz GS. Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice. International Journal of Molecular Sciences. 20. PMID 31540125 DOI: 10.3390/ijms20184566  0.72
2019 Getz GS, Reardon CA. Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis. Frontiers in Pharmacology. 10: 536. PMID 31231209 DOI: 10.3389/fphar.2019.00536  0.72
2018 Getz GS, Reardon CA. T Cells in Atherosclerosis in Ldlr-/- and Apoe-/- Mice. Journal of Immunological Sciences. 2: 69-76. PMID 30854522 DOI: 10.29245/2578-3009/2018/3.1144  0.72
2018 Getz GS, Reardon CA. Apoprotein E and Reverse Cholesterol Transport. International Journal of Molecular Sciences. 19. PMID 30404132 DOI: 10.3390/ijms19113479  0.72
2018 Getz GS, Reardon CA. Diet, Microbes, and Murine Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 38: 2269-2271. PMID 30354225 DOI: 10.1161/ATVBAHA.118.311513  0.72
2018 Fancher IS, Ahn SJ, Adamos C, Osborn C, Oh MJ, Fang Y, Reardon CA, Getz GS, Phillips SA, Levitan I. Hypercholesterolemia-Induced Loss of Flow-Induced Vasodilation and Lesion Formation in Apolipoprotein E-Deficient Mice Critically Depend on Inwardly Rectifying KChannels. Journal of the American Heart Association. 7. PMID 29502106 DOI: 10.1161/JAHA.117.007430  0.72
2018 Subramanian S, Goodspeed L, Wang S, Ding Y, O'Brien KD, Getz GS, Chait A, Reardon CA. Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr-/- Mice. International Journal of Molecular Sciences. 19. PMID 29419749 DOI: 10.3390/ijms19020510  0.72
2017 Pamir N, Hutchins PM, Ronsein GE, Wei H, Tang C, Das R, Vaisar T, Plow E, Schuster V, Reardon CA, Weinberg R, Dichek DA, Marcovina S, Getz GS, Heinecke JW. Plasminogen promotes cholesterol efflux by the ABCA1 pathway. Jci Insight. 2. PMID 28768900 DOI: 10.1172/jci.insight.92176  0.72
2017 Getz GS, Reardon CA. Genetic control of apoprotein A-I and atheroprotection: some insights from inbred strains of mice. Current Opinion in Lipidology. PMID 28731861 DOI: 10.1097/MOL.0000000000000442  0.72
2017 Getz GS, Reardon CA. Natural killer T cells in atherosclerosis. Nature Reviews. Cardiology. PMID 28127028 DOI: 10.1038/nrcardio.2017.2  0.72
2016 Getz GS, Krishack PA, Reardon CA. Serum amyloid A and atherosclerosis. Current Opinion in Lipidology. 27: 531-5. PMID 27579547 DOI: 10.1097/MOL.0000000000000331  0.72
2016 Getz GS, Reardon CA. Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis? Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 27386935 DOI: 10.1161/ATVBAHA.116.306874  0.72
2016 Krishack PA, Sontag TJ, Getz GS, Reardon CA. Serum Amyloid A Regulates Monopoiesis in Hyperlipidemic Ldlr(-/-) Mice. Febs Letters. PMID 27339627 DOI: 10.1002/1873-3468.12269  0.72
2016 Pan Y, Ke H, Yan Z, Geng Y, Asner N, Palani S, Munirathinam G, Dasari S, Nitiss KC, Bliss S, Patel P, Shen H, Reardon CA, Getz GS, Chen A, et al. The western-type diet induces anti-HMGB1 autoimmunity in Apoe(-/-) mice. Atherosclerosis. 251: 31-38. PMID 27240253 DOI: 10.1016/j.atherosclerosis.2016.05.027  0.76
2016 Chellan B, Reardon CA, Getz GS, Hofmann Bowman MA. Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein. Arteriosclerosis, Thrombosis, and Vascular Biology. 36: 1101-13. PMID 27079883 DOI: 10.1161/ATVBAHA.116.307306  0.72
2016 Getz GS, Reardon CA. ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis. Journal of Lipid Research. 57: 758-66. PMID 27015743 DOI: 10.1194/jlr.R067249  0.72
2015 Pamir N, Hutchins P, Ronsein G, Vaisar T, Reardon CA, Getz GS, Lusis AJ, Heinecke JW. Proteomic analysis of HDL from inbred mice strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway. Journal of Lipid Research. PMID 26673204 DOI: 10.1194/jlr.M063701  0.72
2015 Getz GS, Reardon CA. Use of Mouse Models in Atherosclerosis Research. Methods in Molecular Biology (Clifton, N.J.). 1339: 1-16. PMID 26445778 DOI: 10.1007/978-1-4939-2929-0_1  0.72
2015 Getz GS, Reardon CA. Atherogenic lipids and macrophage subsets. Current Opinion in Lipidology. 26: 357-61. PMID 26218415 DOI: 10.1097/MOL.0000000000000217  0.72
2015 Krishack PA, Bhanvadia CV, Lukens J, Sontag TJ, De Beer MC, Getz GS, Reardon CA. Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice. Journal of the American Heart Association. 4. PMID 26187995 DOI: 10.1161/JAHA.115.001858  0.72
2015 Sontag TJ, Chellan B, Bhanvadia CV, Getz GS, Reardon CA. Alginic acid cell entrapment: a novel method for measuring in vivo macrophage cholesterol homeostasis. Journal of Lipid Research. 56: 470-83. PMID 25465389 DOI: 10.1194/jlr.D052985  0.72
2015 Huang ZH, Reardon CA, Getz GS, Maeda N, Mazzone T. Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation. Journal of Lipid Research. 56: 215-26. PMID 25421060 DOI: 10.1194/jlr.M050567  0.72
2014 Getz GS, Reardon CA. The mutual interplay of lipid metabolism and the cells of the immune system in relation to atherosclerosis. Clinical Lipidology. 9: 657-671. PMID 25705263 DOI: 10.2217/clp.14.50  0.72
2014 Kuo CH, Leon L, Chung EJ, Huang RT, Sontag TJ, Reardon CA, Getz GS, Tirrell M, Fang Y. Inhibition of atherosclerosis-promoting microRNAs via targeted polyelectrolyte complex micelles. Journal of Materials Chemistry. B, Materials For Biology and Medicine. 2: 8142-8153. PMID 25685357 DOI: 10.1039/C4TB00977K  0.76
2014 Averill MM, Kim EJ, Goodspeed L, Wang S, Subramanian S, Den Hartigh LJ, Tang C, Ding Y, Reardon CA, Getz GS, Chait A. The apolipoprotein-AI mimetic peptide L4F at a modest dose does not attenuate weight gain, inflammation, or atherosclerosis in LDLR-null mice. Plos One. 9: e109252. PMID 25286043 DOI: 10.1371/journal.pone.0109252  0.72
2014 Wool GD, Reardon CA, Getz GS. Mimetic peptides of human apoA-I helix 10 get together to lower lipids and ameliorate atherosclerosis: is the action in the gut? Journal of Lipid Research. 55: 1983-5. PMID 25085258 DOI: 10.1194/jlr.E053538  0.72
2014 Chen A, Geng Y, Ke H, Constant L, Yan Z, Pan Y, Lee P, Tan I, Williams K, George S, Munirathinam G, Reardon CA, Getz GS, Wang B, Zheng G. Cutting edge: Dexamethasone potentiates the responses of both regulatory T cells and B-1 cells to antigen immunization in the ApoE(-/-) mouse model of atherosclerosis. Journal of Immunology (Baltimore, Md. : 1950). 193: 35-9. PMID 24899497 DOI: 10.4049/jimmunol.1302469  0.72
2014 Getz GS, Reardon CA. Myeloperoxidase-mediated dysfunctional high-density lipoprotein. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 695-6. PMID 24665120 DOI: 10.1161/ATVBAHA.114.303282  0.72
2014 Getz GS, Reardon CA. The structure/function of apoprotein A-I mimetic peptides: an update. Current Opinion in Endocrinology, Diabetes, and Obesity. 21: 129-33. PMID 24569554 DOI: 10.1097/MED.0000000000000045  0.72
2014 Sontag TJ, Krishack PA, Lukens JR, Bhanvadia CV, Getz GS, Reardon CA. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 262-9. PMID 24334873 DOI: 10.1161/ATVBAHA.113.302831  0.76
2013 Subramanian S, Turner MS, Ding Y, Goodspeed L, Wang S, Buckner JH, O'Brien K, Getz GS, Reardon CA, Chait A. Increased levels of invariant natural killer T lymphocytes worsen metabolic abnormalities and atherosclerosis in obese mice. Journal of Lipid Research. 54: 2831-41. PMID 23922382 DOI: 10.1194/jlr.M041020  0.76
2013 Sontag TJ, Chellan B, Getz GS, Reardon CA. Differing rates of cholesterol absorption among inbred mouse strains yield differing levels of HDL-cholesterol. Journal of Lipid Research. 54: 2515-24. PMID 23812556 DOI: 10.1194/jlr.M040055  0.72
2013 Getz GS, Reardon CA. ApoA-I mimetics: tomatoes to the rescue. Journal of Lipid Research. 54: 878-80. PMID 23471030 DOI: 10.1194/jlr.E037572  0.72
2013 Chellan B, Koroleva EP, Sontag TJ, Tumanov AV, Fu YX, Getz GS, Reardon CA. LIGHT/TNFSR14 can regulate hepatic lipase expression by hepatocytes independent of T cells and Kupffer cells. Plos One. 8: e54719. PMID 23355893 DOI: 10.1371/journal.pone.0054719  0.76
2013 Huang ZH, Reardon CA, Subbaiah PV, Getz GS, Mazzone T. ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice. Journal of Lipid Research. 54: 202-13. PMID 23071294 DOI: 10.1194/jlr.M031906  0.72
2012 Szeto FL, Reardon CA, Yoon D, Wang Y, Wong KE, Chen Y, Kong J, Liu SQ, Thadhani R, Getz GS, Li YC. Vitamin D receptor signaling inhibits atherosclerosis in Mice Molecular Endocrinology. 26: 1091-1101. PMID 22638071 DOI: 10.1210/me.2011-1329  0.76
2012 Sontag TJ, Carnemolla R, Vaisar T, Reardon CA, Getz GS. Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein. Journal of Lipid Research. 53: 951-63. PMID 22402133 DOI: 10.1194/jlr.M021154  0.72
2012 Getz GS, Reardon CA. Animal models of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 1104-15. PMID 22383700 DOI: 10.1161/ATVBAHA.111.237693  0.72
2012 LaDu MJ, Munson GW, Jungbauer L, Getz GS, Reardon CA, Tai LM, Yu C. Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift. Biochimica Et Biophysica Acta. 1821: 295-302. PMID 22138302 DOI: 10.1016/j.bbalip.2011.11.005  0.76
2011 Getz GS, Reardon CA. Atherosclerosis: beyond cholesterol. Current Opinion in Lipidology. 22: 507-8. PMID 22101562 DOI: 10.1097/MOL.0b013e32834d179e  0.72
2011 Getz GS, Reardon CA. Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis. Journal of Inflammation Research. 4: 83-92. PMID 22096372 DOI: 10.2147/JIR.S12983  0.72
2011 Tsimikas S, Miyanohara A, Hartvigsen K, Merki E, Shaw PX, Chou MY, Pattison J, Torzewski M, Sollors J, Friedmann T, Lai NC, Hammond HK, Getz GS, Reardon CA, Li AC, et al. Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. Journal of the American College of Cardiology. 58: 1715-27. PMID 21982317 DOI: 10.1016/j.jacc.2011.07.017  0.76
2011 Getz GS, Vanderlaan PA, Reardon CA. Natural killer T cells in lipoprotein metabolism and atherosclerosis. Thrombosis and Haemostasis. 106: 814-9. PMID 21946866 DOI: 10.1160/TH11-05-0336  0.72
2011 Getz GS, Reardon CA. Cubbing in proapolipoprotein maturation. Journal of Lipid Research. 52: 1861-4. PMID 21900175 DOI: 10.1194/jlr.R020149  0.72
2011 Getz GS, Reardon CA. The ABC transporters and the thickening cholesterol plot. Current Opinion in Lipidology. 22: 72-3. PMID 21233623 DOI: 10.1097/MOL.0b013e328342b0fc  0.72
2011 Peng D, Hiipakka RA, Xie JT, Dai Q, Kokontis JM, Reardon CA, Getz GS, Liao S. A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice. British Journal of Pharmacology. 162: 1792-804. PMID 21232031 DOI: 10.1111/j.1476-5381.2011.01202.x  0.72
2011 Wool GD, Cabana VG, Lukens J, Shaw PX, Binder CJ, Witztum JL, Reardon CA, Getz GS. 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 290-300. PMID 20876212 DOI: 10.1096/fj.10-165670  0.72
2010 Getz GS, Wool GD, Reardon CA. HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders. Current Pharmaceutical Design. 16: 3173-84. PMID 20687877  0.72
2010 Getz GS, Reardon CA. High-density lipoprotein function in regulating insulin secretion: possible relevance to metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1497-9. PMID 20631346 DOI: 10.1161/ATVBAHA.110.210583  0.72
2010 Getz GS, Wool GD, Reardon CA. Biological properties of apolipoprotein a-I mimetic peptides. Current Atherosclerosis Reports. 12: 96-104. PMID 20425244 DOI: 10.1007/s11883-010-0097-4  0.72
2010 Sontag TJ, Reardon CA, Getz GS. ABC transporters: lipid transport and inflammation. Current Opinion in Lipidology. 21: 159-60. PMID 20154613 DOI: 10.1097/MOL.0b013e3283376910  0.72
2010 Peng D, Hiipakka RA, Xie JT, Reardon CA, Getz GS, Liao S. Differential effects of activation of liver X receptor on plasma lipid homeostasis in wild-type and lipoprotein clearance-deficient mice. Atherosclerosis. 208: 126-33. PMID 19632679 DOI: 10.1016/j.atherosclerosis.2009.07.016  0.72
2009 Wool GD, Vaisar T, Reardon CA, Getz GS. An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide. Journal of Lipid Research. 50: 1889-900. PMID 19433476 DOI: 10.1194/jlr.M900151-JLR200  0.72
2009 Getz GS, Wool GD, Reardon CA. Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action. Current Opinion in Lipidology. 20: 171-5. PMID 19373084 DOI: 10.1097/MOL.0b013e32832ac051  0.72
2009 Gräbner R, Lötzer K, Döpping S, Hildner M, Radke D, Beer M, Spanbroek R, Lippert B, Reardon CA, Getz GS, Fu YX, Hehlgans T, Mebius RE, van der Wall M, Kruspe D, et al. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. The Journal of Experimental Medicine. 206: 233-48. PMID 19139167 DOI: 10.1084/jem.20080752  0.72
2009 Getz GS, Reardon CA. Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. Journal of Lipid Research. 50: S156-61. PMID 19018038 DOI: 10.1194/jlr.R800058-JLR200  0.72
2009 VanderLaan PA, Reardon CA, Thisted RA, Getz GS. VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. Journal of Lipid Research. 50: 376-85. PMID 18957695 DOI: 10.1194/jlr.M800284-JLR200  0.76
2009 Peng D, Hiipakka RA, Reardon CA, Getz GS, Liao S. Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317. Atherosclerosis. 203: 59-66. PMID 18639878 DOI: 10.1016/j.atherosclerosis.2008.05.058  0.72
2008 Peng D, Hiipakka RA, Dai Q, Guo J, Reardon CA, Getz GS, Liao S. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice. The Journal of Pharmacology and Experimental Therapeutics. 327: 332-42. PMID 18723776 DOI: 10.1124/jpet.108.142687  0.72
2008 Carnemolla R, Ren X, Biswas TK, Meredith SC, Reardon CA, Wang J, Getz GS. The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation. The Journal of Biological Chemistry. 283: 15779-88. PMID 18385132 DOI: 10.1074/jbc.M710244200  0.72
2008 Wool GD, Reardon CA, Getz GS. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. Journal of Lipid Research. 49: 1268-83. PMID 18323574 DOI: 10.1194/jlr.M700552-JLR200  0.72
2008 Getz GS, Reardon CA. SAA, HDL biogenesis, and inflammation. Journal of Lipid Research. 49: 269-70. PMID 18199807 DOI: 10.1194/jlr.E700012-JLR200  0.72
2007 Getz GS, Vanderlaan PA, Reardon CA. The immune system and murine atherosclerosis. Current Drug Targets. 8: 1297-306. PMID 18220706  0.72
2007 Getz GS, Reardon CA. Nutrition and cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 2499-506. PMID 17954523 DOI: 10.1161/ATVBAHA.107.155853  0.72
2007 Lo JC, Wang Y, Tumanov AV, Bamji M, Yao Z, Reardon CA, Getz GS, Fu YX. Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science (New York, N.Y.). 316: 285-8. PMID 17431181 DOI: 10.1126/science.1137221  0.76
2007 VanderLaan PA, Reardon CA, Sagiv Y, Blachowicz L, Lukens J, Nissenbaum M, Wang CR, Getz GS. Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis. The American Journal of Pathology. 170: 1100-7. PMID 17322392 DOI: 10.2353/ajpath.2007.060188  0.72
2006 Getz GS, Reardon CA. Arginine/arginase NO NO NO. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 237-9. PMID 16424360 DOI: 10.1161/01.ATV.0000202014.54609.9d  0.72
2006 LaDu MJ, Stine WB, Narita M, Getz GS, Reardon CA, Bu G. Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein. Biochemistry. 45: 381-90. PMID 16401069 DOI: 10.1021/bi051765s  0.76
2006 Getz GS, Reardon CA. Diet and murine atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 242-9. PMID 16373607 DOI: 10.1161/01.ATV.0000201071.49029.17  0.72
2006 Reardon CA, Blachowicz L, Gupta G, Lukens J, Nissenbaum M, Getz GS. Site-specific influence of polyunsaturated fatty acids on atherosclerosis in immune incompetent LDL receptor deficient mice. Atherosclerosis. 187: 325-31. PMID 16280127 DOI: 10.1016/j.atherosclerosis.2005.10.004  0.72
2005 Ren X, Zhao L, Sivashanmugam A, Miao Y, Korando L, Yang Z, Reardon CA, Getz GS, Brouillette CG, Jerome WG, Wang J. Engineering mouse apolipoprotein A-I into a monomeric, active protein useful for structural determination. Biochemistry. 44: 14907-19. PMID 16274238 DOI: 10.1021/bi0508385  0.72
2005 Lazar KL, Miller-Auer H, Getz GS, Orgel JP, Meredith SC. Helix-turn-helix peptides that form alpha-helical fibrils: turn sequences drive fibril structure. Biochemistry. 44: 12681-9. PMID 16171382 DOI: 10.1021/bi0509705  0.76
2004 Biswas TK, Getz GS. Requirement of different mitochondrial targeting sequences of the yeast mitochondrial transcription factor Mtf1p when synthesized in alternative translation systems. The Biochemical Journal. 383: 383-91. PMID 15257659 DOI: 10.1042/BJ20040691  0.76
2004 Getz GS, Reardon CA. Paraoxonase, a cardioprotective enzyme: continuing issues. Current Opinion in Lipidology. 15: 261-7. PMID 15166781  0.72
2004 Reardon CA, Miller ER, Blachowicz L, Lukens J, Binder CJ, Witztum JL, Getz GS. Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice. Journal of Lipid Research. 45: 1347-54. PMID 15102879 DOI: 10.1194/jlr.M400075-JLR200  0.72
2004 VanderLaan PA, Reardon CA, Getz GS. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 12-22. PMID 14604830 DOI: 10.1161/01.ATV.0000105054.43931.f0  0.72
2004 Cabana VG, Feng N, Reardon CA, Lukens J, Webb NR, de Beer FC, Getz GS. Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro. Journal of Lipid Research. 45: 317-25. PMID 14595002 DOI: 10.1194/jlr.M300414-JLR200  0.72
2003 Edelstein C, Pfaffinger D, Hinman J, Miller E, Lipkind G, Tsimikas S, Bergmark C, Getz GS, Witztum JL, Scanu AM. Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a). The Journal of Biological Chemistry. 278: 52841-7. PMID 14557258 DOI: 10.1074/jbc.M310425200  0.76
2003 Peng D, Song C, Reardon CA, Liao S, Getz GS. Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE. Journal of Neurochemistry. 86: 1391-402. PMID 12950448  0.72
2003 Reardon CA, Blachowicz L, Lukens J, Nissenbaum M, Getz GS. Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1449-54. PMID 12791670 DOI: 10.1161/01.ATV.0000079793.58054.2E  0.72
2003 Cabana VG, Reardon CA, Feng N, Neath S, Lukens J, Getz GS. Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. Journal of Lipid Research. 44: 780-92. PMID 12562837 DOI: 10.1194/jlr.M200432-JLR200  0.72
2002 Biswas TK, Getz GS. Import of yeast mitochondrial transcription factor (Mtf1p) via a nonconventional pathway. The Journal of Biological Chemistry. 277: 45704-14. PMID 12270918 DOI: 10.1074/jbc.M202565200  0.76
2002 Bentley NM, Ladu MJ, Rajan C, Getz GS, Reardon CA. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges. The Biochemical Journal. 366: 273-9. PMID 12015813 DOI: 10.1042/BJ20020207  0.76
2002 Zhu B, Reardon CA, Getz GS, Hui DY. Both apolipoprotein E and immune deficiency exacerbate neointimal hyperplasia after vascular injury in mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 450-5. PMID 11884289  0.72
2002 Reschly EJ, Sorci-Thomas MG, Davidson WS, Meredith SC, Reardon CA, Getz GS. Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution. The Journal of Biological Chemistry. 277: 9645-54. PMID 11744719 DOI: 10.1074/jbc.M107883200  0.72
1968 Getz GS, Bartley W, Lurie D, Notton BM. The phospholipids of various sheep organs, rat liver and of their subcellular fractions. Biochimica Et Biophysica Acta. 152: 325-39. PMID 5639262  1
1962 Bartley W, Getz GS, Notton BM, Renshaw A. The lipid composition of phosphorylating ;digitonin particles' and water- and saline-extracted mitochondria from rat liver. The Biochemical Journal. 82: 540-53. PMID 16748944 DOI: 10.1042/bj0820540  1
1962 GETZ GS, BARTLEY W, STIRPE F, NOTTON BM, RENSHAW A. The lipid composition of rat-liver mitochondria, fluffy layer and microsomes The Biochemical Journal. 83: 181-191. PMID 13898136  0.76
1961 GETZ GS, BARTLEY W, STRIPE F, NOTTON BM, RENSHAW A, ROBINSON DS. The lipid composition of rat-liver cell sap The Biochemical Journal. 81: 214-220. PMID 13898137  0.76
1961 GETZ GS, BARTLEY W. The intracellular distribution of fatty acids in rat liver. The fatty acids of intracellular compartments. The Biochemical Journal. 78: 307-12. PMID 13704843 DOI: 10.1042/bj0780307  1
1961 GETZ GS, BARTLEY W, STIRPE F, NOTTON BM, RENSHAW A. The lipid composition of rat liver The Biochemical Journal. 80: 176-181. PMID 13704842  0.76
1959 GETZ GS, BARTLEY W. A cardiolipin-like compound in rat liver mitochondria. Nature. 184: 1229-30. PMID 13827682 DOI: 10.1038/1841229a0  1
Show low-probability matches.